FDA Will Have To Scrape By On Continuing Resolution Funding Through December, Legislative Experts Predict
Executive Summary
While a government agency shutdown due to lack of agreement between Congress and the Trump administration over funding for the US Food and Drug Administration and other federal agencies seems less likely this year than last, the FDA will still have carry out its 2020 mission in the short term on 2019 continuing resolution funding – probably through December – legislative experts say.
You may also be interested in...
Senate Wants To Keep FDA Device Center At Near-Current Levels In 2020 In 'Minibus' Funding Bill
The US Senate Appropriations Committee has drafted a “minibus” bill covering funding in fiscal year 2020 for five agencies – including the FDA – that would give the agency's device center only $387m. That would keep the center’s spending level approximately the same as it was in FY 2019. The Senate’s proposed spending level is in sharp contrast to what the US House wants for the device center, which is $420m.
Trump Signs 2019 US Federal Funding Bill, Stopping Another FDA Shutdown; CDRH Sees $69M Boost
US FDA’s device center gained a total of $471.4m in budget authority, plus more than $200m that Congress authorized in user-fee funding for the current fiscal year, in a 2019 federal agency spending package signed into law Feb. 15 by the president that prevented a second agency shutdown. The $471.4m budget is roughly $69m more than was given to CDRH for FY 2018.
About Three Months' Worth Of Carryover Device Fees Remaining, FDA's Gottlieb Says
US FDA has about three months' worth of medical device carryover user-fee funds to burn if the partial federal government shutdown continues, although the agency is still finalizing its shutdown balance sheet, Commissioner Scott Gottlieb says.